AAAAAA

   
Results: 1-9 |
Results: 9
Thrombotic events revisited in children with acute lymphoblastic leukemia - Impact of concomitant Escherichia coli asparaginase/prednisone administration
Authors: Nowak-Gottl, U Heinecke, A von Kries, R Nurnberger, W Munchow, N Junker, R
Citation: U. Nowak-gottl et al., Thrombotic events revisited in children with acute lymphoblastic leukemia - Impact of concomitant Escherichia coli asparaginase/prednisone administration, THROMB RES, 103(3), 2001, pp. 165-172
Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia
Authors: Junker, R Koch, HG Auberger, K Munchow, N Ehrenforth, S Nowak-Gottl, U
Citation: R. Junker et al., Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia, ART THROM V, 19(10), 1999, pp. 2568-2572
Search for focus in patients with fever of unknown origin: Is F-18-FDG-PEThelpful?
Authors: Lorenzen, J Buchert, R Bleckmann, C Munchow, N Bohuslavizki, KH
Citation: J. Lorenzen et al., Search for focus in patients with fever of unknown origin: Is F-18-FDG-PEThelpful?, ROFO-F RONT, 171(1), 1999, pp. 49-53
Multicentre evaluation of combined prothrombotic: defects associated with thrombophilia in childhood
Authors: Ehrenforth, S Junker, R Koch, HG Kreuz, W Munchow, N Scharrer, I Nowak-Gottl, U
Citation: S. Ehrenforth et al., Multicentre evaluation of combined prothrombotic: defects associated with thrombophilia in childhood, EUR J PED, 158, 1999, pp. S97-S104
Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis - Evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation
Authors: Schobess, R Junker, R Auberger, K Munchow, N Burdach, S Nowak-Gottl, U
Citation: R. Schobess et al., Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis - Evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation, EUR J PED, 158, 1999, pp. S105-S108
Role of genetic prothrombotic risk factors in childhood caval vein thrombosis
Authors: Munchow, N Kosch, A Schobess, R Junker, R Auberger, K Nowak-Gottl, U
Citation: N. Munchow et al., Role of genetic prothrombotic risk factors in childhood caval vein thrombosis, EUR J PED, 158, 1999, pp. S109-S112
The course of fibrinolytic proteins in children with malignant bone tumours
Authors: Nowak-Gottl, U Munchow, N Klippel, U Paulussen, M Bielack, S Ullrich, K Ehrenforth, S
Citation: U. Nowak-gottl et al., The course of fibrinolytic proteins in children with malignant bone tumours, EUR J PED, 158, 1999, pp. S151-S153
Neoadjuvant therapy for localized extremity osteosarcoma. Experience of the Cooperative Osteosarcoma Study Group COSS with 925 patients
Authors: Bielack, S Kempf-Bielack, B Schwenzer, D Birkfellner, T Delling, G Ewerbeck, V Exner, GU Fuchs, N Gobel, U Graf, N Heise, U Helmke, K von Hochstetter, AR Jurgens, H Maas, R Munchow, N Salzer-Kuntschik, M Treuner, J Veltmann, U Werner, M Winkelmann, W Zoubek, A Kotz, R
Citation: S. Bielack et al., Neoadjuvant therapy for localized extremity osteosarcoma. Experience of the Cooperative Osteosarcoma Study Group COSS with 925 patients, KLIN PADIAT, 211(4), 1999, pp. 260-270
Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood
Authors: Nowak-Gottl, U Junker, R Hartmeier, M Koch, HG Munchow, N Assmann, G von Eckardstein, A
Citation: U. Nowak-gottl et al., Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood, CIRCULATION, 100(7), 1999, pp. 743-748
Risultati: 1-9 |